These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1919 related articles for article (PubMed ID: 28697342)

  • 21. Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes.
    Patil V; Mahalingam K
    Gene; 2019 Feb; 685():85-95. PubMed ID: 30401645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Urokinase Receptor Induces a Mesenchymal Gene Expression Signature in Glioblastoma Cells and Promotes Tumor Cell Survival in Neurospheres.
    Gilder AS; Natali L; Van Dyk DM; Zalfa C; Banki MA; Pizzo DP; Wang H; Klemke RL; Mantuano E; Gonias SL
    Sci Rep; 2018 Feb; 8(1):2982. PubMed ID: 29445239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1.
    Szulzewsky F; Pelz A; Feng X; Synowitz M; Markovic D; Langmann T; Holtman IR; Wang X; Eggen BJ; Boddeke HW; Hambardzumyan D; Wolf SA; Kettenmann H
    PLoS One; 2015; 10(2):e0116644. PubMed ID: 25658639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment.
    van den Bossche WBL; Kleijn A; Teunissen CE; Voerman JSA; Teodosio C; Noske DP; van Dongen JJM; Dirven CMF; Lamfers MLM
    Neuro Oncol; 2018 Oct; 20(11):1494-1504. PubMed ID: 29796615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophages/Microglia in the Glioblastoma Tumor Microenvironment.
    Ma J; Chen CC; Li M
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma.
    Fedele M; Cerchia L; Pegoraro S; Sgarra R; Manfioletti G
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.
    Shibahara I; Saito R; Zhang R; Chonan M; Shoji T; Kanamori M; Sonoda Y; Kumabe T; Kanehira M; Kikuchi T; So T; Watanabe T; Takahashi H; Iwabuchi E; Tanaka Y; Shibahara Y; Sasano H; Ishii N; Tominaga T
    Mol Cancer; 2015 Feb; 14():41. PubMed ID: 25744203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM.
    Ge H; Mu L; Jin L; Yang C; Chang YE; Long Y; DeLeon G; Deleyrolle L; Mitchell DA; Kubilis PS; Lu D; Qi J; Gu Y; Lin Z; Huang J
    Int J Cancer; 2017 Oct; 141(7):1434-1444. PubMed ID: 28612394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors.
    Kaffes I; Szulzewsky F; Chen Z; Herting CJ; Gabanic B; Velázquez Vega JE; Shelton J; Switchenko JM; Ross JL; McSwain LF; Huse JT; Westermark B; Nelander S; Forsberg-Nilsson K; Uhrbom L; Maturi NP; Cimino PJ; Holland EC; Kettenmann H; Brennan CW; Brat DJ; Hambardzumyan D
    Oncoimmunology; 2019; 8(11):e1655360. PubMed ID: 31646100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.
    Kwon SM; Kang SH; Park CK; Jung S; Park ES; Lee JS; Kim SH; Woo HG
    PLoS One; 2015; 10(10):e0140528. PubMed ID: 26466313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma.
    Roesch S; Rapp C; Dettling S; Herold-Mende C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Athymic mice reveal a requirement for T-cell-microglia interactions in establishing a microenvironment supportive of
    Pan Y; Xiong M; Chen R; Ma Y; Corman C; Maricos M; Kindler U; Semtner M; Chen YH; Dahiya S; Gutmann DH
    Genes Dev; 2018 Apr; 32(7-8):491-496. PubMed ID: 29632086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
    Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
    J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
    Perea F; Bernal M; Sánchez-Palencia A; Carretero J; Torres C; Bayarri C; Gómez-Morales M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2017 Feb; 140(4):888-899. PubMed ID: 27785783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma.
    Chen YP; Yin JH; Li WF; Li HJ; Chen DP; Zhang CJ; Lv JW; Wang YQ; Li XM; Li JY; Zhang PP; Li YQ; He QM; Yang XJ; Lei Y; Tang LL; Zhou GQ; Mao YP; Wei C; Xiong KX; Zhang HB; Zhu SD; Hou Y; Sun Y; Dean M; Amit I; Wu K; Kuang DM; Li GB; Liu N; Ma J
    Cell Res; 2020 Nov; 30(11):1024-1042. PubMed ID: 32686767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microenvironment-Derived Regulation of HIF Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme.
    Heiland DH; Gaebelein A; Börries M; Wörner J; Pompe N; Franco P; Heynckes S; Bartholomae M; hAilín DÓ; Carro MS; Prinz M; Weber S; Mader I; Delev D; Schnell O
    Mol Cancer Res; 2018 Apr; 16(4):655-668. PubMed ID: 29330292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mining TCGA database for genes of prognostic value in glioblastoma microenvironment.
    Jia D; Li S; Li D; Xue H; Yang D; Liu Y
    Aging (Albany NY); 2018 Apr; 10(4):592-605. PubMed ID: 29676997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenomic analysis reveals LGALS1 contributes to the immune heterogeneity and immunosuppression in glioma.
    Chen Q; Han B; Meng X; Duan C; Yang C; Wu Z; Magafurov D; Zhao S; Safin S; Jiang C; Cai J
    Int J Cancer; 2019 Jul; 145(2):517-530. PubMed ID: 30613962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A three ion channel genes-based signature predicts prognosis of primary glioblastoma patients and reveals a chemotherapy sensitive subtype.
    Wang HY; Li JY; Liu X; Yan XY; Wang W; Wu F; Liang TY; Yang F; Hu HM; Mao HX; Liu YW; Zhang SZ
    Oncotarget; 2016 Nov; 7(46):74895-74903. PubMed ID: 27713134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
    Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
    J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 96.